# Adebrelimab + Apatinib in SCLC Maintenance Therapy

Source: https://onco.cc/trials/nct06475209/  
OnCo record `nct06475209` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of adebrelimab and rivoceranib (apatinib) in lung cancer, run by Tang-Du Hospital, now recruiting.

## Summary

Adebrelimab + Apatinib in SCLC Maintenance Therapy is a phase 2, interventional study registered as NCT06475209 by Tang-Du Hospital, with a registry enrolment figure of 60 participants, started 2024-06-20 and due to reach its primary completion in 2025-12-20. Interventions recorded: Adebrelimab combined with Apatinib. Conditions listed: SCLC. Primary outcome: Progression-free survival. Lung eligibility wording from the registry: "Histologically or cytologically confirmed extensive-stage small cell lung cancer (LS-SCLC) according to the AJCC 8th edition or VALG phase II staging criteria". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06475209
- Phase: 2
- Setting: Observational Study on the Efficacy and Safety of Adebrelimab Combined With Apatinib in Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Sponsor: Tang-Du Hospital
- Enrolled: 60

## Sources

- ClinicalTrials.gov NCT06475209: https://clinicaltrials.gov/study/NCT06475209

## Connected records

- cancers: [Extensive-stage small-cell lung cancer](https://onco.cc/cancers/extensive-stage-sclc/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Rivoceranib (apatinib)](https://onco.cc/drugs/rivoceranib/)
- companies: [Jiangsu Hengrui Pharmaceuticals](https://onco.cc/companies/hengrui/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06475209.json